Editing GSK plc (section)

=== Recent developments ===
In April 2022, the business announced it would acquire Sierra Oncology Inc for $1.9 billion ($55 per share).<ref>{{Cite news |last1=Grover |first1=Natalie |last2=Shabong |first2=Yadarisa |date=13 April 2022 |title=GSK to buy Sierra Oncology amid pressure to boost drug pipeline |newspaper=Reuters |url=https://www.reuters.com/business/healthcare-pharmaceuticals/gsk-buy-sierra-oncology-19-billion-2022-04-13/ |archive-url=https://web.archive.org/web/20220413065844/https://www.reuters.com/business/healthcare-pharmaceuticals/gsk-buy-sierra-oncology-19-billion-2022-04-13/ |archive-date=13 April 2022 |via=www.reuters.com}}</ref> In May 2022, GSK announced it would acquire Affinivax and its phase II 24-valent [[pneumococcal]] vaccine candidate for up to $3.3 billion, strengthening its vaccine business.<ref>{{cite news |last=Keown |first=Alex |date=31 May 2022 |title=GSK Bolsters Vaccines Business with $3.3B Affinivax Buy |newspaper=Biospace |url=https://www.biospace.com/article/gsk-bolsters-vaccines-business-with-affinivax-buy/?s=79 |access-date=9 June 2022 |archive-url=https://web.archive.org/web/20230205012142/https://www.biospace.com/article/gsk-bolsters-vaccines-business-with-affinivax-buy/?s=79 |archive-date=5 February 2023}}</ref>

On 16 May 2022, the company changed its name from GlaxoSmithKline to GSK.<ref>{{cite web |date=16 May 2022 |title=Change of name |url=https://www.londonstockexchange.com/news-article/GSK/change-of-name-to-gsk-plc/15454280 |url-status=live |archive-url=https://web.archive.org/web/20220517145739/https://www.londonstockexchange.com/news-article/GSK/change-of-name-to-gsk-plc/15454280 |archive-date=17 May 2022 |access-date=2 June 2022 |publisher=London Stock Exchange}}</ref>

In April 2023, GSK announced it would acquire Bellus Health Inc. for $2 billion.<ref>{{Cite web |last=Susin |first=Michael |date=18 April 2023 |title=GSK: To Acquire The Late-stage Biopharmaceutical Group For $14.75 Per Share |url=https://www.marketwatch.com/story/gsk-to-acquire-the-late-stage-biopharmaceutical-group-for-14-75-per-share-ed67d6d |url-status=usurped |archive-url=https://web.archive.org/web/20230418064221/https://www.marketwatch.com/story/gsk-to-acquire-the-late-stage-biopharmaceutical-group-for-14-75-per-share-ed67d6d |archive-date=18 April 2023 |access-date=18 April 2023 |website=MarketWatch |language=EN-US}}</ref>

In February 2024, the company acquired [[Aiolos Bio]] for over $1 billion, adding to its existing asthma business through [[AIO-001]] a long-acting [[monoclonal antibody]] that targets the [[thymic stromal lymphopoietin]] cytokine.<ref>{{cite web |url=https://www.biospace.com/article/gsk-puts-1-4b-on-the-line-in-aiolos-acquisition-to-boost-asthma-pipeline/?s=79 |title=GSK Puts $1.4B on the Line in Aiolos Acquisition to Boost Asthma Pipeline|date=9 January 2024 }}</ref><ref>{{Cite web |date=February 16, 2024 |title=GSK completes acquisition of Aiolos Bio for up to $1.4 bln |url=https://www.reuters.com/business/healthcare-pharmaceuticals/gsk-completes-acquisition-aiolos-bio-up-14-bln-2024-02-15/ |access-date=February 16, 2024 |website=Reuters}}</ref>

In May 2024, GSK sold off its 4.2% shares in Haleon for $1.58 billion.<ref>{{Cite web |title=GSK sells off remaining stake in Haleon |url=https://www.ft.com/content/557b7f43-da17-46b6-aa1c-740c1859fa96 |access-date=2024-05-17 |website=www.ft.com|date=17 May 2024 | vauthors = Johnston I }}</ref><ref>{{Cite web |title=GSK to sell remaining 4.2% stake in Haleon |url=https://www.sharecast.com/news/news-and-announcements/gsk-to-sell-remaining-42-stake-in-haleon--16794044.html |access-date=2024-05-17 |website=Sharecast |language=en}}</ref><ref>{{Cite news |title=GSK Sells Last Haleon Shares for $1.58 Bln |newspaper=Marketwatch |url=https://www.marketwatch.com/story/gsk-sells-last-haleon-shares-for-1-58-bln-c99ca63f}}</ref>

In July 2024, GSK moved its headquarters from Brentford to [[Oxford Street|New Oxford Street]] in central London.<ref>{{Cite web |date=2024-07-13 |title=GSK moves to new HQ in return to central London |url=https://www.independent.co.uk/news/uk/gsk-london-emma-walmsley-brentford-city-b2579395.html |access-date=2024-07-16 |website=The Independent |language=en}}</ref>

====Acquisition-history diagram====
{{hidden begin|border=1px #aaa solid|title=GlaxoSmithKline Structure|ta1=center}}
{{Tree list}}
* '''GSK'''
** GlaxoSmithKline
*** SmithKline Beecham Plc {{small|(Renamed 1989)}}
**** SmithKline Beckman {{small|(Renamed 1982)}}
***** SmithKline-RIT {{small|(Renamed 1968)}}
****** [[Smith, Kline & French]] {{small|(Reorganized 1929 into Smith Kline and French Laboratories)}}
******* French, Richards and Company {{small|(Acquired 1891)}}
******* Smith, Kline and Company
****** [[Recherche et Industrie Thérapeutiques]] {{small|(Acquired 1968)}}
***** [[Beckman Instruments, Inc.]] {{small|(Merged 1982, Sold 1989)}}
****** Specialized Instruments Corp. {{small|(Acquired 1954)}}
****** Offner Electronics {{small|(Acquired 1961)}}
***** International Clinical Laboratories {{small|(Acquired 1989)}}
***** Reckitt & Colman {{small|(Acquired 1999)}}
**** [[Beecham Group]] Plc {{small|(Merged 1989)}}
***** Beecham Group Ltd
****** [[S. E. Massengill Company]] {{small|(Acquired 1971)}}
****** C.L. Bencard {{small|(Acquired 1953)}}
****** County Chemicals
***** Norcliff Thayer {{small|(Acquired 1986)}}
*** Glaxo Wellcome
**** Glaxo {{small|(Merged 1995)}}
***** Joseph Nathan & Co
***** [[Allen & Hanburys]] {{small|(Founded 1715, acquired 1958)}}
***** Meyer Laboratories {{small|(Merged 1978)}}
***** Affymax {{small|(Acquired 1995)}}
**** Wellcome Foundation {{small|(Renamed 1924, merged 1995)}}
***** Burroughs Wellcome & Company {{small|(Founded 1880)}}
***** McDougall & Robertson Inc {{small|(Acquired 1959)}}
** [[Block Drug]] {{small|(Acquired 2001)}}
** CNS Inc. {{small|(Acquired 2006)}}
** [[Stiefel Laboratories]] {{small|(Acquired 2009)}}
** Laboratorios Phoenix {{small|(Acquired 2010)}}
** Maxinutrition {{small|(Acquired 2010)}}
** CellZome {{small|(Acquired 2011)}}
** [[Human Genome Sciences]] {{small|(Acquired 2013)}}
** GlycoVaxyn {{small|(Acquired 2015)}}
** [[Tesaro]] {{small|(Acquired 2019)}}
** Sitari Pharmaceuticals {{small|(Acquired 2019)}}
** Sierra Oncology {{small|(Acquired 2022)}}
** Affinivax {{small|(Acquired 2022)}}
** Bellus Health Inc. {{small|(Acquired 2023)}}
** Aiolos Bio {{small|(Acquired 2024)}}
{{Tree list/end}}
{{Hidden end}}